Middle Aged – Page 4 – HCV Guidance

Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir

May 25, 2017
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent

May 23, 2017
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection

May 23, 2017
Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection

May 23, 2017
Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report

May 23, 2017
Direct-acting antiviral treatment in adults infected with hepatitis C virus: reactivation of hepatitis B virus coinfection as a further challenge

May 23, 2017
Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease

May 23, 2017
Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network

May 23, 2017
Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the chronic hepatitis cohort study (CHeCS)

May 23, 2017
Hepatitis B virus reactivation during successful treatment of hepatitis C virus with sofosbuvir and simeprevir

May 18, 2017